Literature DB >> 27279251

β-Blockers and Vascular Hemodynamics in Patients With Peripheral Arterial Disease.

Oliver Schlager1, Ludmila Gajdosova Kovacicova2, Oliver Senn3, Beatrice Amann-Vesti2, Ian B Wilkinson4, Vincenzo Jacomella2, Marc Husmann2.   

Abstract

Aortic augmentation index (AIx) is a marker of central aortic pressure burden and is modulated by antihypertensive drugs. In patients with peripheral arterial disease (PAD) undergoing antihypertensive treatment, aortic pressures parameters, heart rate-adjusted augmentation index (AIx75), and unadjusted AIx were determined. The (aortic) systolic and diastolic blood pressure did not differ between PAD patients who were taking β-blockers (n=61) and those who were not taking β-blockers (n=80). In patients taking β-blockers, augmentation pressure and pulse pressure were higher than in patients who did not take β-blockers (augmentation pressure, P=.02; pulse pressure, P=.005). AIx75 was lower in PAD patients taking β-blockers than in patients not taking β-blockers (P=.04), while the AIx did not differ between PAD patients taking and not taking β-blockers. The present study demonstrates that β-blockers potentially affect markers of vascular hemodynamics in patients with PAD. Because these markers are surrogates of cardiovascular risk, further studies are warranted to clarify the impact of selective β-blocker treatment on clinical outcome in patients with PAD. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27279251      PMCID: PMC8031715          DOI: 10.1111/jch.12854

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

Review 1.  beta-adrenergic receptor blockade in chronic heart failure.

Authors:  M R Bristow
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

Review 2.  Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery.

Authors:  Katayoun Mostafaie; Rachel Bedenis; Darrell Harrington
Journal:  Cochrane Database Syst Rev       Date:  2015-01-14

3.  Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform.

Authors:  A L Pauca; M F O'Rourke; N D Kon
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

4.  Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease.

Authors:  Julio A Chirinos; Juan P Zambrano; Simon Chakko; Anila Veerani; Alan Schob; Howard J Willens; Guido Perez; Armando J Mendez
Journal:  Hypertension       Date:  2005-04-18       Impact factor: 10.190

5.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

6.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

7.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

8.  The impact of endovascular lower-limb revascularisation on the aortic augmentation index in patients with peripheral arterial disease.

Authors:  V Jacomella; A Shenoy; K Mosimann; M K Kohler; B Amann-Vesti; M Husmann
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-02-28       Impact factor: 7.069

9.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

10.  The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care.

Authors:  A T Hirsch; S L Halverson; D Treat-Jacobson; P S Hotvedt; M M Lunzer; S Krook; S Rajala; D B Hunninghake
Journal:  Vasc Med       Date:  2001       Impact factor: 3.239

View more
  1 in total

1.  β-Blockers and Vascular Hemodynamics in Patients With Peripheral Arterial Disease.

Authors:  Oliver Schlager; Ludmila Gajdosova Kovacicova; Oliver Senn; Beatrice Amann-Vesti; Ian B Wilkinson; Vincenzo Jacomella; Marc Husmann
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-08       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.